Advanced image processing techniques and mathematics merged with biochemistry expertise made Z3 possible. The initial version of Z3 was launched in September 2000 and sales started in mid October. We are very pleased that within only 90 days from the initial sales efforts, Z3 has been purchased by an impressive group of leading scientific institutions, in addition to hundreds of beta installments worldwide. This allows comparison of differential protein expression between normal and diseased tissues. The new version's, upgraded features include the capability to create one image from several gels of the same sample, allowing for a more accurate and robust analysis, an advanced protein annotation feature, and the ability to predict the PI and mass of protein components of the sample.
Additional features allow personalized analysis in a user-friendly environment.
The new Z3 version supports Windows 2000 as well as Windows 98 and NT 4.0. Prohost is an independent publication providing information on biotech companies. Prohost does not accept compensation from companies that are featured or profiled. It is strongly recommended that any purchase or sale decisions to any of the featured companies be discussed with a financial advisor or broker prior to completing any such purchase or sale decision. All statements or expressions are the opinion of Prohost and are not meant to be a solicitation or recommendation to buy, sell, or hold securities.